Despite a declining overall incidence of prostate cancer in the United States, a CDC analysis revealed the incidence of metastatic prostate cancer is increasing.
Jason M. Broderick
Advertisement
Articles by Jason M. Broderick
The BCMA-targeting CAR T-cell therapy yielded a response in73% of patients with heavily pretreated relapsed/refractory multiple myeloma.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
BI-1808 Combo Improves Efficacy vs Pembrolizumab Alone in Ovarian Cancer
2
Subcutaneous Isatuximab Regimens Show Efficacy in R/R Multiple Myeloma
3
FDA OKs Study Progression of (Z)-Endoxifen in Metastatic Breast Cancer
4
Intravenous Olvi-Vec Yields Responses in NSCLC and SCLC Following Progression
5